SYNJARDY 12.5/850MG TABS 60’S

Synjardy 12.5/850 mg is a prescription medication that combines two active ingredients: empagliflozin and metformin. It is primarily used for the management of type 2 diabetes mellitus in adults. Empagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that helps lower blood sugar levels by preventing glucose reabsorption in the kidneys, leading to increased glucose excretion in urine. Metformin, on the other hand, is a biguanide that improves insulin sensitivity, decreases hepatic glucose production, and enhances peripheral glucose uptake and utilization.

Synjardy is typically prescribed to improve glycemic control in conjunction with diet and exercise. It may be used alone or in combination with other antidiabetic medications. Additionally, it has been shown to have cardiovascular benefits in patients with type 2 diabetes and established cardiovascular disease. Regular monitoring of kidney function is recommended while on this medication.